Show simple item record

Pol theta inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance

dc.contributor.authorZatreanu, DA
dc.contributor.authorRobinson, HMR
dc.contributor.authorAlkhatib, O
dc.contributor.authorBoursier, M
dc.contributor.authorFinch, H
dc.contributor.authorGeo, L
dc.contributor.authorGrande, D
dc.contributor.authorGrinkevich, V
dc.contributor.authorHeald, R
dc.contributor.authorLangdon, S
dc.contributor.authorMajithiya, J
dc.contributor.authorMcWhirter, C
dc.contributor.authorMartin, NMB
dc.contributor.authorMoore, S
dc.contributor.authorNeves, J
dc.contributor.authorRajendra, E
dc.contributor.authorRanzani, M
dc.contributor.authorSchaedler, T
dc.contributor.authorStockley, M
dc.contributor.authorWiggins, K
dc.contributor.authorBrough, R
dc.contributor.authorSridhar, S
dc.contributor.authorGulati, A
dc.contributor.authorShao, N
dc.contributor.authorBadder, LM
dc.contributor.authorNovo, D
dc.contributor.authorKnight, EG
dc.contributor.authorMarlow, R
dc.contributor.authorHaider, S
dc.contributor.authorCallen, E
dc.contributor.authorHewitt, G
dc.contributor.authorSchimmel, J
dc.contributor.authorPrevo, R
dc.contributor.authorAlli, C
dc.contributor.authorFerdinand, A
dc.contributor.authorBell, C
dc.contributor.authorBlencowe, P
dc.contributor.authorCalder, M
dc.contributor.authorCharles, M
dc.contributor.authorCurry, J
dc.contributor.authorEkwuru, T
dc.contributor.authorEwings, K
dc.contributor.authorNussenzweig, A
dc.contributor.authorTijsterman, M
dc.contributor.authorTutt, A
dc.contributor.authorBoulton, SJ
dc.contributor.authorHiggins, GS
dc.contributor.authorPettitt, S
dc.contributor.authorSmith, GCM
dc.contributor.authorLord, CJ
dc.date.accessioned2022-05-04T09:27:56Z
dc.date.available2022-05-04T09:27:56Z
dc.date.issued2021-12-01
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000776028100106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifier.citationMOLECULAR CANCER THERAPEUTICS, 2021, 20 (12), pp. ? - ? (3)
dc.identifier.issn1535-7163
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5106
dc.identifier.eissn1538-8514
dc.identifier.doi10.1158/1535-7163.TARG-21-P056
dc.format.extent? - ? (3)
dc.language.isoeng
dc.publisherAMER ASSOC CANCER RESEARCH
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.titlePol theta inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
dc.typeConference Proceeding
dcterms.dateAccepted2021-04-30
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1158/1535-7163.TARG-21-P056
rioxxterms.licenseref.startdate2021-12-01
dc.relation.isPartOfMOLECULAR CANCER THERAPEUTICS
pubs.issue12
pubs.notesNot known
pubs.organisational-group/ICR
pubs.publication-statusPublished
pubs.volume20
pubs.embargo.termsNot known
dc.contributor.icrauthorHaider, Syed


Files in this item

Thumbnail
Name:
Polθ inhibitors elicit BRCA-gene ...
Size:
31.36Mb
Format:
PDF
Description:
Published version
View/Open

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/